Global Structural Heart Imaging (SHI) Market to Reach US$45.8 Billion by 2030
The global market for Structural Heart Imaging (SHI) estimated at US$24.5 Billion in the year 2023, is expected to reach US$45.8 Billion by 2030, growing at a CAGR of 9.4% over the analysis period 2023-2030. Echocardiogram Modality, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$27.5 Billion by the end of the analysis period. Growth in the MRI Modality segment is estimated at 9.9% CAGR over the analysis period.
The U.S. Market is Estimated at US$6.4 Billion While China is Forecast to Grow at 12.6% CAGR
The Structural Heart Imaging (SHI) market in the U.S. is estimated at US$6.4 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$10.5 Billion by the year 2030 trailing a CAGR of 12.6% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.1% and 7.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.0% CAGR.
Global Structural Heart Imaging (SHI) Market - Key Trends and Drivers Summarized
How Is Structural Heart Imaging Transforming Cardiac Care?
Structural Heart Imaging (SHI) is a critical aspect of modern cardiology, providing detailed visualization of the heart’s structure, including valves, chambers, and surrounding vessels. This imaging technique plays a pivotal role in diagnosing and treating structural heart diseases such as valvular heart disease, septal defects, and congenital abnormalities. It encompasses several imaging modalities, including echocardiography, cardiac MRI, CT scans, and 3D imaging, each offering precise visualization to guide minimally invasive procedures like transcatheter aortic valve replacement (TAVR) and mitral valve repair. As the demand for non-invasive cardiac treatments grows, SHI has become indispensable for accurate diagnosis, treatment planning, and patient monitoring in structural heart disease.
What Are the Key Segments in the Structural Heart Imaging Market?
Key modalities include echocardiography, cardiac MRI, computed tomography (CT), and nuclear imaging, with echocardiography holding the largest market share due to its widespread use in real-time heart assessments and pre-procedural planning. Applications cover valvular heart disease, congenital heart defects, cardiomyopathies, and coronary artery disease, with valvular heart disease representing a significant segment driven by the increasing prevalence of aortic stenosis and mitral regurgitation in aging populations. End-users include hospitals, ambulatory surgical centers, and diagnostic imaging centers, with hospitals leading the market as they conduct advanced cardiac imaging for both inpatient and outpatient care.
How Is Structural Heart Imaging Integrated Across Cardiology?
In the diagnosis of valvular heart disease, echocardiography is used to assess valve morphology, function, and blood flow, helping cardiologists determine the severity of stenosis or regurgitation and guide treatment decisions. In congenital heart disease, advanced imaging techniques like cardiac MRI and 3D CT scans offer detailed anatomical visualization, supporting surgical planning and interventional procedures. For patients undergoing transcatheter interventions, SHI is crucial for pre-procedural planning, intraoperative guidance, and post-procedural monitoring, ensuring successful outcomes. Additionally, structural heart imaging aids in risk stratification, enabling physicians to predict complications, monitor disease progression, and tailor interventions for individual patients.
What Factors Are Driving the Growth in the Structural Heart Imaging Market?
The growth in the Structural Heart Imaging market is driven by several factors, including increasing demand for accurate diagnosis and minimally invasive treatment of structural heart diseases. Advancements in imaging technologies, such as real-time 3D imaging, improved resolution, and AI integration, have enhanced diagnostic accuracy, procedural planning, and patient outcomes, supporting broader adoption across cardiology. The focus on managing cardiovascular diseases, particularly in aging populations with valvular disorders, has further fueled demand, as SHI enables early detection, precise interventions, and effective monitoring. Additionally, rising healthcare investments, the expansion of cardiac care facilities, and growing awareness of non-invasive treatments have contributed to market growth, encouraging the integration of advanced imaging techniques in structural heart care.
SCOPE OF STUDY:Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook